Barinthus Biotherapeutics plc (BRNS) NASDAQ
0.60
+0.0599(+11.09%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.60
+0.0599(+11.09%)
Currency In USD
| Market Cap | 28.37M |
| Enterprise Value | -30.8M |
| P/E Ratio | -0.37 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.33 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.59 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.68 |
| Return On Equity | -0.71 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -5.86M |
| EBITDA | -48.34M |
| Net Income | -66.43M |
| Diluted EPS | -1.64 |
| Total Cash | 70.46M |
| Total Cash/Share | 1.74 |
| Total Debt | 11.28M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 7.77 |
| Book Value Per Share | 1.83 |
| 52-Week Change | -12.02 |
| 52-Week High | 2.92 |
| 52-Week Low | 0.51 |
| Moving Average 50 Days | 0.64 |
| Moving Average 200 Days | 0.97 |
| Average Volume | 46,872 |
| Shares Outstanding | 40.85M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |